{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:19:22Z","timestamp":1778887162841,"version":"3.51.4"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bbr.2024.115092","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:39:43Z","timestamp":1717483183000},"page":"115092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Experimental Parkinson models and green chemistry approach"],"prefix":"10.1016","volume":"471","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-1884","authenticated-orcid":false,"given":"Ozge","family":"Akyaz\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-6591","authenticated-orcid":false,"given":"D\u0131lara","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6204-2845","authenticated-orcid":false,"given":"Sule Coskun","family":"Cevher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bjorl.2014.05.032","article-title":"Postural control in Parkinson\u2019s disease.","volume":"80","author":"Fukunaga","year":"2014","journal-title":"Braz. J. Otorhinolaryngol."},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/NHH.0000000000000398","article-title":"Parkinson Disease","volume":"34","author":"Capriotti","year":"2016","journal-title":"Home Healthc. Now."},{"issue":"10","key":"10.1016\/j.bbr.2024.115092_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047138","article-title":"The effect of motivation on movement: a study of Bradykinesia in Parkinson\u2019s disease","volume":"7","author":"Shiner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2024.115092_bib5","first-page":"43","article-title":"The retropulsion test: a good evaluation of postural instability in Parkinson\u2019s disease","volume":"5","author":"Nonnekes","year":"2015","journal-title":"J. Park. \u2019S. Dis."},{"issue":"8","key":"10.1016\/j.bbr.2024.115092_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1700","article-title":"Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders","volume":"10","author":"Kowalska-Taczanowska","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbr.2024.115092_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bbr.2024.115092_bib8","first-page":"377","article-title":"Park\u0131nson's d\u0131sease.","volume":"48","author":"Bene","year":"2009","journal-title":"Acta Clin. Croat."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med"},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbr.2024.115092_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson's disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities","volume":"28","author":"Schmidt","year":"2021","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.bbr.2024.115092_bib14","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in Parkinson's disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.17343\/sdutfd.447542","article-title":"Parkinson hastal\u0131\u011f\u0131nda n\u00f6roinflamasyonun rol\u00fc","volume":"26","author":"Ta\u015fdemir","year":"2019","journal-title":"Med J. SDU \/ SD\u00dc T\u0131p Fak. Derg."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem"},{"key":"10.1016\/j.bbr.2024.115092_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fneur.2013.00033","article-title":"Molecular events underlying Parkinson\u2019s disease-an interwoven tapestry","volume":"4","author":"Lim","year":"2013","journal-title":"Front Neurol."},{"key":"10.1016\/j.bbr.2024.115092_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","article-title":"Autophagy and apoptosis dysfunction in neurodegenerative disorders","volume":"112","author":"Ghavami","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha-Synuclein as a Biomarker for Parkinson's Disease","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13425","article-title":"Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics","volume":"139","author":"Belaidi","year":"2016","journal-title":"J. Neurochem"},{"key":"10.1016\/j.bbr.2024.115092_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nm.2668","article-title":"Ironing out tau's role in parkinsonism","volume":"18","author":"Stankowski","year":"2012","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.bbr.2024.115092_bib24","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3390\/biomedicines11113094","article-title":"On the Role of Iron in Idiopathic Parkinson\u2019s Disease","volume":"11","author":"Huenchuguala","year":"2023","journal-title":"Biomedicines"},{"issue":"23","key":"10.1016\/j.bbr.2024.115092_bib25","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.3390\/cells11233829","article-title":"Iron brain menace: the involvement of ferroptosis in Parkinson disease","volume":"11","author":"Lin","year":"2022","journal-title":"Cells 29"},{"key":"10.1016\/j.bbr.2024.115092_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41419-021-04490-1","article-title":"Double-edge sword roles of iron in driving energy production versus instigating ferroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib27","unstructured":"Ay M. Translational drug discovery approaches targeting the PKD1 signaling in Parkinson\u2019s disease, Iowa State University. (2016)."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/j.bbr.2024.115092_bib29","first-page":"1","article-title":"Parkinson hastal\u0131\u011f\u0131n\u0131n etyopatogenezi","volume":"7","author":"Akbay\u0131r","year":"2017","journal-title":"Deney. T\u0131p Derg."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0037-1601567","article-title":"Genetic Forms of Parkinson's Disease","volume":"37","author":"Kim","year":"2017","journal-title":"Semin Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib31","first-page":"3","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"issue":"19","key":"10.1016\/j.bbr.2024.115092_bib32","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.3390\/molecules25194382","article-title":"The pathology of Parkinson\u2019s disease and potential benefit of dietary polyphenols","volume":"25","author":"Aryal","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2024.115092_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Review: Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"issue":"17","key":"10.1016\/j.bbr.2024.115092_bib35","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.3390\/ijms20174121","article-title":"Probiotics for Parkinson's Disease","volume":"20","author":"Gazerani","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbr.2024.115092_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","article-title":"Parkinson's disease outside the brain: targeting the autonomic nervous system","volume":"20","author":"Sharabi","year":"2021","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.bbr.2024.115092_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson's: a syndrome rather than a disease","volume":"124","author":"Titova","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin. Geriatr. Med"},{"key":"10.1016\/j.bbr.2024.115092_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105332","article-title":"Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy","volume":"153","author":"Brumberg","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib40","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson\u2019s disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib41","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2024.115092_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2024.115092_bib43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbr.2024.115092_bib44","first-page":"3769","article-title":"The tail suspension test","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070249","article-title":"Non-motor and motor features in LRRK2 transgenic mice","volume":"8","author":"Bichler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2024.115092_bib46","first-page":"127","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail Parkinsonian models","volume":"10","author":"Maasz","year":"2017","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.bbr.2024.115092_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mp.2013.3","article-title":"Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson\u2019s disease","volume":"19","author":"Drui","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2024.115092_bib48","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3945\/jn.117.255034","article-title":"Epigallocatechin gallate has a neurorescue effect in a mouse model of Parkinson disease","volume":"147","author":"Xu","year":"2017","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbr.2024.115092_bib49","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1073\/pnas.1814909116","article-title":"Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bbr.2024.115092_bib50","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.7150\/thno.80271","article-title":"Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease","volume":"13","author":"Zheng","year":"2023","journal-title":"Theranostics"},{"issue":"30","key":"10.1016\/j.bbr.2024.115092_bib51","article-title":"Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats","volume":"5","author":"Oliynyk","year":"2023","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbr.2024.115092_bib52","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajp.22281","article-title":"Why primate models matter","volume":"76","author":"Phillips","year":"2014","journal-title":"Am. J. Prima"},{"key":"10.1016\/j.bbr.2024.115092_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Non-human primate models of Parkinson's disease","volume":"48","author":"Emborg","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.bbr.2024.115092_bib54","doi-asserted-by":"crossref","first-page":"105606","DOI":"10.18632\/oncotarget.22348","article-title":"Pilot study: molecular risk factors for diagnosing sporadic Parkinson\u2019s disease based on gene expression in blood in MPTP-induced rhesus monkeys","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bbr.2024.115092_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202770","article-title":"Charting the onset of Parkinson-like motor and non-motor symptoms in non-human primate model of Parkinson's disease.","volume":"13","author":"Choudhury","year":"2018","journal-title":"Plos One"},{"issue":"12","key":"10.1016\/j.bbr.2024.115092_bib56","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1093\/brain\/awad331","article-title":"Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates","volume":"146","author":"Chocarro","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2024.115092_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2020.09.004","article-title":"Striatal oscillations in Parkinsonian non-human primates","volume":"449","author":"Singh","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2024.115092_bib58","first-page":"17","article-title":"Modeling Parkinson\u2019s disease in C. elegans","volume":"8","author":"Cooper","year":"2018","journal-title":"J. Park. \u2019S. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.695718","article-title":"Modeling Parkinson\u2019s disease: not only rodents","volume":"13","author":"Shadrina","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2010.05.012","article-title":"Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans","volume":"40","author":"-Dimitriadi","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1534\/genetics.119.302964","article-title":"Large-scale transgenic drosophila resource collections for loss- and gain-of-function studies","volume":"214","author":"Zirin","year":"2020","journal-title":"Genetics"},{"issue":"11","key":"10.1016\/j.bbr.2024.115092_bib62","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1080\/15548627.2018.1491489","article-title":"The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain","volume":"14","author":"Issa","year":"2018","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/hmg\/ddu430","article-title":"A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila","volume":"24","author":"Cassar","year":"2015","journal-title":"Hum. Mol. Genet"},{"issue":"7446","key":"10.1016\/j.bbr.2024.115092_bib64","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"25","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2024.115092_bib65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fneur.2018.00347","article-title":"Zebrafish as an animal model for drug discovery in parkinson\u2019s disease and other movement disorders: a systematic review","volume":"9","author":"Vaz","year":"2018","journal-title":"Front Neurol."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib66","first-page":"811","article-title":"Long-term drug administration in the adult zebrafish using oral gavage for cancer preclinical studies","volume":"9","author":"Dang","year":"2016","journal-title":"Dis. Model Mech."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005065","article-title":"Viable neuronopathic gaucher disease model in medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein","volume":"11","author":"Uemura","year":"2015","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054424","article-title":"Establishment of HRASG12V transgenic medaka as a stable tumor model for in vivo screening of anticancer drugs","volume":"8","author":"Matsuzaki","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.bbr.2024.115092_bib69","doi-asserted-by":"crossref","first-page":"10766","DOI":"10.3390\/ijms221910766","article-title":"Zebrafish and medaka: important animal models for human neurodegenerative diseases","volume":"22","author":"Wang","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418777438","article-title":"Neurotoxin-induced animal models of parkinson disease: pathogenic mechanism and assessment","volume":"10","author":"Zeng","year":"2018","journal-title":"ASN Neuro"},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib71","first-page":"294","article-title":"Antioxidant and anti-inflammatory potential of Hesperidin against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced experimental Parkinson's disease in mice","volume":"3","author":"Tamilselvam","year":"2018","journal-title":"Int. J. Nutr., Pharmacol., Neurol. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib72","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.bbr.2024.115092_bib73","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1017\/S0317167100046345","article-title":"The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man","volume":"11","author":"Burns","year":"1984","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib74","first-page":"11","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"J. Park. Dis."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib75","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pbb.2011.05.007","article-title":"Aged monkeys as a partial model for Parkinson's disease","volume":"99","author":"Hurley","year":"2011","journal-title":"Pharm. Biochem Behav."},{"issue":"23","key":"10.1016\/j.bbr.2024.115092_bib76","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1111\/bph.14823","article-title":"Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1","volume":"176","author":"Geng","year":"2019","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib77","first-page":"422","article-title":"MPTP-induced mouse model of Parkinson\u2019s disease: a promising direction for therapeutic strategies","volume":"21","author":"Mustapha","year":"2021","journal-title":"Bosn. J. Basic Med Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173742","article-title":"Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys","volume":"892","author":"Bonif\u00e1cio","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib79","first-page":"19","article-title":"MPTP mouse models of Parkinson\u2019s disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1474-9726.2011.00721.x","article-title":"DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson\u2019s disease","volume":"10","author":"Wang","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbr.2024.115092_bib81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med"},{"issue":"18","key":"10.1016\/j.bbr.2024.115092_bib82","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","article-title":"VMAT2 knockout mice:heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion and enhanced MPTP toxicity","volume":"94","author":"Takahashi","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-4159.2007.05108.x","article-title":"VMAT2 and dopamine neuron loss in a primate model of Parkinson\u2019s disease","volume":"105","author":"Chen","year":"2008","journal-title":"J. Neurochem"},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib84","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nbd.2005.01.014","article-title":"Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells","volume":"19","author":"Chen","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib85","first-page":"17","article-title":"Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease","volume":"11","author":"Watanabe","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbr.2024.115092_bib86","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fncel.2017.00241","article-title":"AF-6 protects against dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease","volume":"11","author":"Basil","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib87","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.18632\/oncotarget.14650","article-title":"Oxidative stress in neurodegenerative disease:causation or association","volume":"8","author":"Van Raamsdonk","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib88","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","article-title":"Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease","volume":"219","author":"Meredith","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2024.115092_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655819","article-title":"Genetic imaging of neuroinflammation in Parkinson\u2019s disease: recent advancements","volume":"9","author":"Yao","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib90","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/ijbs.8366","article-title":"Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP","volume":"10","author":"Lu","year":"2014","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib91","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2024.115092_bib92","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.bbr.2024.115092_bib93","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3390\/ijms21103459","article-title":"Impact of aging on the 6-OHDA-induced rat model of Parkinson\u2019s disease","volume":"21","author":"Barata-Antunes","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.33549\/physiolres.933895","article-title":"In vivo, in vitro and pharmacologic models of Parkinson's disease","volume":"68","author":"Salari","year":"2019","journal-title":"Physiol. Res."},{"issue":"60","key":"10.1016\/j.bbr.2024.115092_bib95","first-page":"3234","article-title":"Development of a unilaterally-lesioned 6-OHDA mouse model of parkinson's disease","author":"Thiele","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"12","key":"10.1016\/j.bbr.2024.115092_bib96","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.3390\/cells10123548","article-title":"The neuroprotective effects of the CB2 agonist GW842166x in the 6-OHDA mouse model of Parkinson's disease","volume":"10","author":"Yu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2024.115092_bib97","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson\u2019s disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbr.2024.115092_bib98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2013.11.003","article-title":"Rotenone and paraquat perturb dopamine metabolism: a computational analysis of pesticide toxicity","volume":"315","author":"Qui","year":"2014","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib99","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10654-011-9574-5","article-title":"Parkinson\u2019s disease risk from ambient exposure to pesticides","volume":"26","author":"Wang","year":"2011","journal-title":"Eur. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.bbr.2024.115092_bib101","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1289\/ehp.7570","article-title":"Developmental pesticide models of the Parkinson disease phenotype","volume":"113","author":"Cory-Slechta","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbr.2024.115092_bib102","article-title":"Pesticides DEET, fipronil and maneb induce stress granule assembly and translation arrest in neuronal cells","volume":"28","author":"Bhadauriya","year":"2021","journal-title":"Biochem Biophys. Rep."},{"key":"10.1016\/j.bbr.2024.115092_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1100\/tsw.2001.35","article-title":"Pesticides and Parkinson\u2019s Disease","volume":"1","author":"Sherer","year":"2001","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bbr.2024.115092_bib104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2202-15-21","article-title":"Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson\u2019s disease","volume":"15","author":"Muthukumaran","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbr.2024.115092_bib105","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2008.10.045","article-title":"Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation","volume":"46","author":"Peng","year":"2009","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.bbr.2024.115092_bib106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00204-017-2133-4","article-title":"An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition","volume":"92","author":"Terron","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbr.2024.115092_bib107","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2012.06.025","article-title":"Gene-environment interactions in Parkinson\u2019s disease: Specific evidence in humans and mammalian models.","volume":"57","author":"Cannon","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib108","doi-asserted-by":"crossref","first-page":"26895","DOI":"10.1074\/jbc.M114.591354","article-title":"Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid beta-oxidation, supporting acetyl-coenzyme A levels","volume":"289","author":"Worth","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12906-019-2738-7","article-title":"Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo","volume":"20","author":"-Wang","year":"2020","journal-title":"BMC Complement Med Ther."},{"issue":"5","key":"10.1016\/j.bbr.2024.115092_bib110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","article-title":"Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models","volume":"14","author":"Liu","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.bbr.2024.115092_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595635","article-title":"Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson's disease","volume":"11","author":"Patricio","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.bbr.2024.115092_bib112","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/aje\/kwp006","article-title":"Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California","volume":"169","author":"Costello","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbr.2024.115092_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.644219","article-title":"Resveratrol in rodent models of parkinson's disease: a systematic review of experimental studies","volume":"12","author":"Su","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.bbr.2024.115092_bib114","doi-asserted-by":"crossref","unstructured":"Konnova E.A., Swanberg M. Animal Models of Parkinson\u2019s Disease [Internet]. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Brisbane (AU): Codon Publications. (2018):Chapter 5.","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch5"},{"issue":"24","key":"10.1016\/j.bbr.2024.115092_bib115","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson\u2019s disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib116","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2353\/ajpath.2007.060359","article-title":"Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model","volume":"170","author":"Norris","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib117","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1673-5374.380878","article-title":"Single-neuron neurodegeneration as a degenerative model for Parkinson\u2019s disease","volume":"19","author":"Huenchuguala","year":"2024","journal-title":"Neural Regen. Res"},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib118","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/antiox11020296","article-title":"Neuroprotection against aminochrome neurotoxicity: glutathione transferase M2-2 and DT-diaphorase","volume":"11","author":"Segura-Aguilar","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib119","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/antiox12030673","article-title":"A preclinical model for Parkinson\u2019s disease based on transcriptional gene activation via KEAP1\/NRF2 to develop new antioxidant therapies","volume":"12","author":"Segura-Aguilar","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbr.2024.115092_bib120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib121","article-title":"Potential of animal models for advancing the understanding and treatment of pain in Parkinson\u2019s disease","volume":"6","author":"Buhidma","year":"2020","journal-title":"NPJ Park. Dis."},{"issue":"21","key":"10.1016\/j.bbr.2024.115092_bib122","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.3390\/ijms20215402","article-title":"Animal models for Parkinson's disease research: trends in the 2000s","volume":"20","author":"Kin","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib123","article-title":"Limitations of animal models of Parkinson\u2019s disease","volume":"2010","author":"Potashkin","year":"2011","journal-title":"Park. \u2019S. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib124","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2024.115092_bib125","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1073\/pnas.171300598","article-title":"alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins","volume":"98","author":"Sharon","year":"2001","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"10.1016\/j.bbr.2024.115092_bib126","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction","volume":"9","author":"Lautenschlager","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2024.115092_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087133","article-title":"Targeting the intrinsically disordered structural ensemble of alpha-synuclein by small molecules as a potential therapeutic strategy for Parkinson\u2019s disease","volume":"9","author":"Toth","year":"2014","journal-title":"Plos One"},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbadis.2008.10.005","article-title":"Genetic models of Parkinson disease","volume":"1792","author":"Lim","year":"2009","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.bbr.2024.115092_bib129","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of \u03b1-synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016706","article-title":"Resistance to MPTP-neurotoxicity in \u03b1-synuclein knockout mice is complemented by human \u03b1-synuclein and associated with increased \u03b2-synuclein and Akt activation","volume":"6","author":"Thomas","year":"2011","journal-title":"PloS ONE"},{"key":"10.1016\/j.bbr.2024.115092_bib131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"2. Parkinson\u2019s disease \u03b1-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2024.115092_bib132","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1523\/JNEUROSCI.3040-07.2008","article-title":"Neurodegeneration and motor dysfunction in a conditional model of Parkinson\u2019s disease","volume":"28","author":"Nuber","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2024.115092_bib133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.expneurol.2007.09.011","article-title":"In vivo gene delivery for development of mammalian models for Parkinson's disease","volume":"209","author":"Ulusoy","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2024.115092_bib134","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2005.035568","article-title":"The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson\u2019s disease and originates from a common ancestor","volume":"42","author":"Goldwurm","year":"2005","journal-title":"J. Med Genet"},{"key":"10.1016\/j.bbr.2024.115092_bib135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2024.115092_bib136","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2024.115092_bib137","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib138","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2005.12.004","article-title":"LRRK2: a common pathway for parkinsonism, pathogenesis and prevention","volume":"12","author":"Taylor","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib139","first-page":"5661","article-title":"Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity","volume":"275","author":"\u0130mai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2024.115092_bib140","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1523\/JNEUROSCI.2172-05.2005","article-title":"Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, pp38\/JTV-1, leads to catecholaminergic cell death","volume":"25","author":"Ko","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2024.115092_bib141","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2024.115092_bib142","doi-asserted-by":"crossref","first-page":"16193","DOI":"10.1074\/jbc.C600041200","article-title":"Identification of far upstream element-binding protein-1 as an authentic Parkin substrate","volume":"281","author":"Ko","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2024.115092_bib143","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism","volume":"299","author":"Bonifati","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbr.2024.115092_bib144","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbr.2024.115092_bib145","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1073\/pnas.0602493103","article-title":"Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin","volume":"103","author":"Yang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2024.115092_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PloS ONE"},{"key":"10.1016\/j.bbr.2024.115092_bib147","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bbr.2024.115092_bib148","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009324","article-title":"Animal models of Parkinson's disease: vertebrate genetics","volume":"2","author":"Lee","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib149","first-page":"45","article-title":"The current medical management of Parkinson\u2019s disease. Parkinson Hast.","volume":"11","author":"Erer","year":"2008","journal-title":"Hareket Boz. Der."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib150","first-page":"176","article-title":"A systematic review on Parkinson's disease (PD)","volume":"3","author":"Rewar","year":"2015","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib151","first-page":"195","article-title":"Gene therapy for Parkinson's disease, an update","volume":"8","author":"Axelsen","year":"2018","journal-title":"J. Park. Dis."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib152","first-page":"570","article-title":"Invest\u0131gat\u0131on on the neuroprotect\u0131ve effects of hesper\u0131d\u0131n on behav\u0131oural act\u0131v\u0131t\u0131es in 6-Ohda induced park\u0131nson model","volume":"5","author":"Nagappan","year":"2014","journal-title":"Int J. Pharm. Bio Sci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib153","first-page":"275","article-title":"Extract reduces oxidative stress and improves symptoms in 6-hydroxydopamine-induced Parkinson's disease in rats","volume":"15","author":"Rezaei","year":"2016","journal-title":"Iran. J. Pharm. Res. Winter"},{"key":"10.1016\/j.bbr.2024.115092_bib154","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9923331","article-title":"The positive role and mechanism of herbal medicine in Parkinson's Disease","author":"Yin","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"14","key":"10.1016\/j.bbr.2024.115092_bib155","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.3390\/ijms20143380","article-title":"Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer's Disease and Parkinson's Disease","volume":"20","author":"Nakajima","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib156","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.nut.2014.03.024","article-title":"Protective effect of Hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice","volume":"30","author":"Antunes","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.bbr.2024.115092_bib157","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.freeradbiomed.2005.04.022","article-title":"Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS\u2013NO pathway.","volume":"39","author":"Guo","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"14","key":"10.1016\/j.bbr.2024.115092_bib158","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.3390\/molecules28145415","article-title":"Polyphenols and neurodegenerative diseases: potential effects and mechanisms of neuroprotection","volume":"28","author":"Arias-S\u00e1nchez","year":"2023","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bbr.2024.115092_bib159","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.3390\/molecules25194382","article-title":"The pathology of Parkinson\u2019s disease and potential benefit of dietary polyphenols.","volume":"25","author":"Aryal","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib160","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/ijms21072564","article-title":"Bioactive polyphenols and neuromodulation: molecular mechanisms in neurodegeneration","volume":"21","author":"Di Meo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.bbr.2024.115092_bib161","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.3390\/molecules24234335","article-title":"A switch between antioxidant and prooxidant properties of the phenolic compounds myricetin, Morin, 3\u2032, 4\u2032-dihydroxyflavone, taxifolin and 4-hydroxy-coumarin in the presence of copper (II) ions: a spectroscopic, absorption titration and DNA damage study","volume":"24","author":"Jomov\u00e1","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bbr.2024.115092_bib162","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3390\/ijms20123056","article-title":"The potential of flavonoids for the treatment of neurodegenerative diseases","volume":"20","author":"Maher","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib163","first-page":"1443","article-title":"Morin'in Karbonik Anhidraz, Asetilkolinesteraz ve \u03b1-glikozidaz Enzimleri \u00dczerindeki \u0130nhibisyon Etkileri","volume":"9","author":"Ca\u011flayan","year":"2019","journal-title":"J. Inst. Sci. Technol."},{"issue":"10","key":"10.1016\/j.bbr.2024.115092_bib164","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jnr.23764","article-title":"Neuroprotective and anti-inflammatory effects of Morin in a murine model of Parkinson's disease.","volume":"94","author":"Lee","year":"2016","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.bbr.2024.115092_bib165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.freeradbiomed.2003.11.023","article-title":"Flavonoid permeability across an in situ model of the blood\u2013brain barrier","volume":"36","author":"Youdim","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2024.115092_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101911","article-title":"Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson's disease","volume":"41","author":"Han","year":"2021","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.bbr.2024.115092_bib167","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3390\/molecules23061297","article-title":"Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases","volume":"23","author":"Pervin","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2024.115092_bib168","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/molecules23030512","article-title":"Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2024.115092_bib169","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7043213","article-title":"Flavonoids as therapeutic agents in Alzheimer\u2019s and Parkinson\u2019s diseases: a systematic review of preclinical evidences","author":"de Andrade Teles","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.bbr.2024.115092_bib170","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6038996","article-title":"Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer\u2019s disease","author":"Minocha","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.bbr.2024.115092_bib171","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2018.00422","article-title":"Anti-parkinson potential of silymarin: mechanistic insight and therapeutic standing","volume":"9","author":"Ullah","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbr.2024.115092_bib172","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2174\/1570159X21666230203101107","article-title":"New perspectives of taxifolin in neurodegenerative diseases","volume":"21","author":"Yang","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2024.115092_bib173","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23022","article-title":"Dihydroquercetin improves rotenone-induced parkinsonism by regulating NF-\u03baB-mediated inflammation pathway in rats","volume":"36","author":"Akinmoladun","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib174","first-page":"524","article-title":"Investigating the basis for the antidepressant effects of Gleditsiae spina using an integrated metabolomic strategy","volume":"24","author":"Liu","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21315\/mjms2023.30.2.2","article-title":"Beneficial Role of Vitexin in Parkinson's Disease","volume":"30","author":"Mustapha","year":"2023","journal-title":"Malays. J. Med Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4785089","article-title":"A brief review on the neuroprotective mechanisms of vitexin","volume":"2018","author":"Lima","year":"2018","journal-title":"Biomed. Res Int"},{"issue":"5","key":"10.1016\/j.bbr.2024.115092_bib177","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10571-015-0264-9","article-title":"alpha-Mangostin Inhibits alpha-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity","volume":"36","author":"Hu","year":"2016","journal-title":"Cell Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23225","article-title":"Irisflorentin promotes bacterial phagocytosis and inhibits inflammatory responses in macrophages during bacterial infection","volume":"10","author":"Xiang","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib179","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7603\/s40681-015-0004-y","article-title":"Irisflorentin improves \u03b1-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson\u2019s disease therapy","volume":"5","author":"Chen","year":"2015","journal-title":"Biomedicine"},{"issue":"18","key":"10.1016\/j.bbr.2024.115092_bib180","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.3390\/ijms231810578","article-title":"Anti-inflammatory and neuroprotective effects of morin in an MPTP-induced parkinson\u2019s disease model.","volume":"23","author":"Hong","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbr.2024.115092_bib181","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/aps.2010.77","article-title":"Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo","volume":"31","author":"Zhang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbr.2024.115092_bib182","article-title":"Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement","volume":"1789","author":"Ishola","year":"2002","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib183","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/antiox9070609","article-title":"Antioxidant and anti-inflammatory effects of citrus flavonoid hesperetin: Special focus on neurological disorders","volume":"9","author":"Khan","year":"2020","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.bbr.2024.115092_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11440","article-title":"Potential therapeutic use of plant flavonoids in AD and PD","volume":"8","author":"Meng-Zhen","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bbr.2024.115092_bib185","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","article-title":"Hesperidin ameliorates anxiety-depressive-like behavior in 6-OHDA model of Parkinson\u2019s disease by regulating striatal cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice","volume":"57","author":"Antunes","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib186","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/molecules24030648","article-title":"Hesperidin as a neuroprotective agent: a review of animal and clinical evidence","volume":"24","author":"Hajialyani","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2024.115092_bib187","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/102741","article-title":"Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson\u2019s disease","volume":"2013","author":"Tamilselvam","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib188","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/2231-0738.114875","article-title":"Antioxidant and anti-inflammatory potential of hesperidin aganist 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced experimantal parkinson\u2019s disease in mice.","volume":"3","author":"Tamilselvam","year":"2013","journal-title":"Int. J. Nutr., Pharmacol., Neurol. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib189","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuro.2022.02.004","article-title":"Improvement of non-motor and motor and behavioral alterations associated with Parkinson-like disease in Drosophila melanogaster: comparative effects of treatments with hesperidin and L-dopa","volume":"89","author":"Poetini","year":"2002","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.bbr.2024.115092_bib190","unstructured":"\u00c7oban, D. Ge\u00e7 K vitamini eksikli\u011finde g\u00f6r\u00fclen n\u00f6rolojik sekeller.(Doctoral Thesis). YOKTEZ. (2007): 3-8."},{"issue":"12","key":"10.1016\/j.bbr.2024.115092_bib191","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3390\/foods10123136","article-title":"Relationship between structure and biological activity of various vitamin K forms","volume":"10","author":"Bus","year":"2021","journal-title":"Foods"},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib192","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/antiox10040566","article-title":"The role of vitamin k in humans: Implication in aging and age-associated diseases","volume":"10","author":"Popa","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib193","first-page":"5329","article-title":"Vitamin K: the effect on health beyond coagulation-an overview","volume":"56","author":"Vermeer","year":"2012","journal-title":"Food Res."},{"issue":"4","key":"10.1016\/j.bbr.2024.115092_bib194","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/ijms20040896","article-title":"Vitamin K: double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease","volume":"20","author":"Halder","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbr.2024.115092_bib195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/aps.2016.68","article-title":"Vitamin K2 suppresses rotenone-induced microglial activation in vitro","volume":"37","author":"Yu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bbr.2024.115092_bib196","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/biof.1004","article-title":"an emerging nutrient in brain function","volume":"38","author":"Ferland","year":"2012","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib197","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11033-022-07925-w","article-title":"The emerging relationship between vitamin K and neurodegenerative diseases: A review of current evidence","volume":"50","author":"Emekli-Alturfan","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbr.2024.115092_bib198","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/s41598-021-82724-0","article-title":"Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice","volume":"11","author":"Weisell","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2024.115092_bib199","doi-asserted-by":"crossref","first-page":"362","DOI":"10.18229\/kocatepetip.605508","article-title":"Multipl sklerozda K vitamininin rol\u00fc var m\u0131d\u0131r?","volume":"21","author":"\u00d6zdemir","year":"2020","journal-title":"Kocatepe T\u0131p Derg."},{"issue":"7","key":"10.1016\/j.bbr.2024.115092_bib200","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3390\/nu13072206","article-title":"Vitamin K2 holds promise for Alzheimer's prevention and treatment","volume":"13","author":"Popescu","year":"2021","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.bbr.2024.115092_bib201","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2021e11679","article-title":"Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease","volume":"54","author":"Ribeiro-Carvalho","year":"2021","journal-title":"Braz. J. Med Biol. Res"},{"issue":"3","key":"10.1016\/j.bbr.2024.115092_bib202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229769","article-title":"Neuroprotective effect of menaquinone-4 (MK-4) on transient global cerebral ischemia\/reperfusion injury in rat","volume":"15","author":"Farhadi Moghadam","year":"2020","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bbr.2024.115092_bib203","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.3390\/ijms20143380","article-title":"Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"20","author":"Nakajima","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.bbr.2024.115092_bib204","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1021\/acs.jafc.9b00133","article-title":"Nobiletin protects against systemic inflammation-stimulated memory impairment via MAPK and NF-\u03baB signaling pathways","volume":"67","author":"Qi","year":"2019","journal-title":"J. Agric. Food Chem."},{"issue":"23","key":"10.1016\/j.bbr.2024.115092_bib205","doi-asserted-by":"crossref","first-page":"12805","DOI":"10.3390\/ijms222312805","article-title":"Neurotoxicity and underlying mechanisms of endogenous neurotoxins","volume":"22","author":"Cao","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115092_bib206","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease:no evidence of benefit","volume":"71","author":"Parkinson Study Group QE3 Investigators","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbr.2024.115092_bib207","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2024.115092_bib208","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"Isradipine versus placebo in early Parkinson disease:a randomized trial","volume":"172","author":"Simuni","year":"2020","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.bbr.2024.115092_bib209","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamaneurol.2020.4725","article-title":"Efficacy of nilotinib in patients with moderately advanced Parkinson disease:a randomized clinical trial","volume":"78","author":"Simuni","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbr.2024.115092_bib210","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1474-4422(06)70602-0","article-title":"TCH346 as a neuroprotective drug in Parkinson's disease:a double-blind, randomised, controlled trial","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2024.115092_bib211","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of cinpanemab in early Parkinson's disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.bbr.2024.115092_bib212","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6281454","article-title":"Foods with potential prooxidant and antioxidant effects involved in Parkinson's disease","volume":"2020","author":"Miranda-D\u00edaz","year":"2020","journal-title":"Oxid. Med Cell Longev."},{"issue":"3-4","key":"10.1016\/j.bbr.2024.115092_bib213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/07435809909066147","article-title":"Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen","volume":"25","author":"Medina-Navarro","year":"2009","journal-title":"Endocr. Res."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib214","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1472-8206.2005.00389.x","article-title":"Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect","volume":"20","author":"Buyukavci","year":"2006","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2024.115092_bib215","first-page":"1","article-title":"Dietary Interventions in Parkinson's Disease","volume":"14","author":"Van der Berg","year":"2024","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbr.2024.115092_bib216","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson\u2019s disease: a pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov. Disord."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432824002481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432824002481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T01:50:56Z","timestamp":1732153856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432824002481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":216,"alternative-id":["S0166432824002481"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2024.115092","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental Parkinson models and green chemistry approach","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2024.115092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115092"}}